ASHLEY SHAVER: Open Payments
NPI 1932829009 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,213 in 110 payments from 21 companies in 2025. Trend: 2023 $639 · 2024 $875 · 2025 $2,213
Food & beverage: $2,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $431 |
| AstraZeneca Pharmaceuticals LP | 16 | $414 |
| Lilly USA, LLC | 13 | $275 |
| Novo Nordisk Inc | 10 | $232 |
| PFIZER INC. | 15 | $179 |
| GlaxoSmithKline, LLC. | 10 | $178 |
| Ardelyx, Inc. | 4 | $96 |
| Lundbeck LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Exact Sciences Corporation | 2 | $43 |
Products named: VRAYLAR, BREZTRI, MOUNJARO, REXULTI, JARDIANCE, Wegovy, TRELEGY ELLIPTA, IBSRELA.
Industry payments across CT — which companies pay providers there.
